China approves human trial of Covid vaccines produced from insect cells | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
May 29, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, MAY 29, 2025
China approves human trial of Covid vaccines produced from insect cells

Coronavirus chronicle

UNB/Xinhua
26 August, 2020, 01:45 pm
Last modified: 26 August, 2020, 01:51 pm

Related News

  • Commerce minister's visit to elevate Dhaka-Beijing comprehensive ties to new heights: Ambassador Yao
  • Bangladeshi mangoes enter Chinese markets to boost bilateral trade: Ambassador Yao
  • Residents pick up the pieces one day after deadly China chemical blast
  • Mango exports to China begins tomorrow
  • Weak Chinese demand leaves Australia with too much wheat

China approves human trial of Covid vaccines produced from insect cells

The vaccine is designed to trigger antibodies against specific areas on the spike protein of SARS-CoV-2, the virus that causes Covid-19

UNB/Xinhua
26 August, 2020, 01:45 pm
Last modified: 26 August, 2020, 01:51 pm
Photo: Xinhua via UNB
Photo: Xinhua via UNB

China has approved the human trial of a new Covid-19 vaccine produced by using insect cells, said Chinese officials.

Vaccine developers at the West China Hospital of Sichuan University Monday said the recombinant protein vaccine was issued with a clinical research permit from the National Medical Products Administration, reports Xinhua.

According to researchers, it will be China's first Covid-19 vaccine candidate grown in insect cells for humans.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The vaccine is designed to trigger antibodies against specific areas on the spike protein of SARS-CoV-2, the virus that causes Covid-19.

China's Sinovac enters supply deal with Indonesia for Covid-19 vaccine doses

The results of animal tests were published in the journal Nature on July 29, which showed that the vaccine could induce immune responses against SARS-CoV-2 infection in mice, rabbits and non-human primates as early as seven or 14 days after a single dose injection, with 'no obvious' side effects.

Co-author Wei Yuquan, a senior researcher of the hospital's state key laboratory of biotherapy, said the vaccine was produced by inserting genes of the SARS-CoV-2 virus into insect cell cultures, which can grow viral proteins.

Such an approach is suitable for large-scale manufacturing of vaccines.

Scientists have previously used insect cells to develop recombinant vaccines against cervical cancer and influenza in Western countries, said Wei, adding that the approach can be safely used on humans.

The Chengdu-based hospital is also cooperating with a local company to design a vaccine production line.

Top News

China / Vaccine / Insect

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • How termination of USDA-funded trade facilitation project will affect Bangladesh
    How termination of USDA-funded trade facilitation project will affect Bangladesh
  • File photo of Bangladesh Secretariat. Photo: Collected
    Visitors banned from entering Secretariat on Mondays and Thursdays
  • File photo of BNP Secretary General Mirza Fakhrul Islam Alamgir. Photo: Collected
    Asked for roadmap, govt didn’t give in 10 months, now 'December it is': Mirza Fakhrul

MOST VIEWED

  • Google Pay. Photo: Collected
    Google Pay likely coming to Bangladesh soon
  • Graphics: TBS
    Suspicious banking activities surge by 56% since July: Cenbank
  • Representational image of cable car/Freepik
    Cable car to be installed from Himchari to Reju Khal in Marine Drive Road
  • Illustration: TBS
    Bangladesh sees highest-ever per capita income of $2,820 in FY25, BBS provisional data shows
  • IFIC Bank receives Tk6,000 cr in new deposits in six months
    IFIC Bank receives Tk6,000 cr in new deposits in six months
  • Abdul Awal Mintoo, chairman of National Bank Limited. Sketch: TBS
    'Regulatory support must for National Bank to restore depositors' confidence'

Related News

  • Commerce minister's visit to elevate Dhaka-Beijing comprehensive ties to new heights: Ambassador Yao
  • Bangladeshi mangoes enter Chinese markets to boost bilateral trade: Ambassador Yao
  • Residents pick up the pieces one day after deadly China chemical blast
  • Mango exports to China begins tomorrow
  • Weak Chinese demand leaves Australia with too much wheat

Features

In recent years, the Gor-e-Shaheed Eidgah has emerged as a strong contender for the crown of the biggest Eid congregation in the country, having hosted 600,000 worshippers in 2017. Photo: TBS

Gor-e-Shaheed Boro Maath: The heart of Dinajpur

2d | Panorama
The Hili Land Port, officially opened in 1997 but with trade roots stretching back to before Partition, has grown into a cornerstone of bilateral commerce.

Dhaka-Delhi tensions ripple across Hili’s markets and livelihoods

3d | Panorama
Photo: Collected

Desk goals: Affordable ways to elevate your study setup

3d | Brands
Built on a diamond-type frame, the Hornet 2.0 is agile but grounded. PHOTO: Asif Chowdhury

Honda Hornet 2.0: Same spirit, upgraded sting

3d | Wheels

More Videos from TBS

The fight between two brothers; Adidas vs Puma

The fight between two brothers; Adidas vs Puma

6h | Others
Trump is again keen to make Canada the 51st state

Trump is again keen to make Canada the 51st state

7h | Others
Trump's tariff strategy and Europe's investment politics, violence or negotiation?

Trump's tariff strategy and Europe's investment politics, violence or negotiation?

8h | Others
Rumours surrounding the Club World Cup: Which club will Ronaldo join?

Rumours surrounding the Club World Cup: Which club will Ronaldo join?

8h | Others
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net